| pubmed-article:11405491 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11405491 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11405491 | lifeskim:mentions | umls-concept:C0376466 | lld:lifeskim |
| pubmed-article:11405491 | lifeskim:mentions | umls-concept:C0010055 | lld:lifeskim |
| pubmed-article:11405491 | lifeskim:mentions | umls-concept:C0079189 | lld:lifeskim |
| pubmed-article:11405491 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:11405491 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:11405491 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:11405491 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:11405491 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:11405491 | pubmed:dateCreated | 2001-6-14 | lld:pubmed |
| pubmed-article:11405491 | pubmed:abstractText | The release of proinflammatory cytokines has been shown to be associated with the development of complications after coronary artery bypass grafting with cardiopulmonary bypass. The purpose of the present study was to establish whether ischemic preconditioning (IP) could limit inflammatory cytokines release in patients undergoing elective coronary artery bypass surgery. | lld:pubmed |
| pubmed-article:11405491 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11405491 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11405491 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11405491 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11405491 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11405491 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11405491 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11405491 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11405491 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11405491 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:11405491 | pubmed:issn | 1401-7431 | lld:pubmed |
| pubmed-article:11405491 | pubmed:author | pubmed-author:LaineSS | lld:pubmed |
| pubmed-article:11405491 | pubmed:author | pubmed-author:KaukinenSS | lld:pubmed |
| pubmed-article:11405491 | pubmed:author | pubmed-author:WehLL | lld:pubmed |
| pubmed-article:11405491 | pubmed:author | pubmed-author:TarkkaMM | lld:pubmed |
| pubmed-article:11405491 | pubmed:author | pubmed-author:KuukasjärviPP | lld:pubmed |
| pubmed-article:11405491 | pubmed:author | pubmed-author:LaurikkaJJ | lld:pubmed |
| pubmed-article:11405491 | pubmed:author | pubmed-author:PehkonenEE | lld:pubmed |
| pubmed-article:11405491 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11405491 | pubmed:volume | 35 | lld:pubmed |
| pubmed-article:11405491 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11405491 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11405491 | pubmed:pagination | 142-6 | lld:pubmed |
| pubmed-article:11405491 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11405491 | pubmed:meshHeading | pubmed-meshheading:11405491... | lld:pubmed |
| pubmed-article:11405491 | pubmed:meshHeading | pubmed-meshheading:11405491... | lld:pubmed |
| pubmed-article:11405491 | pubmed:meshHeading | pubmed-meshheading:11405491... | lld:pubmed |
| pubmed-article:11405491 | pubmed:meshHeading | pubmed-meshheading:11405491... | lld:pubmed |
| pubmed-article:11405491 | pubmed:meshHeading | pubmed-meshheading:11405491... | lld:pubmed |
| pubmed-article:11405491 | pubmed:meshHeading | pubmed-meshheading:11405491... | lld:pubmed |
| pubmed-article:11405491 | pubmed:meshHeading | pubmed-meshheading:11405491... | lld:pubmed |
| pubmed-article:11405491 | pubmed:meshHeading | pubmed-meshheading:11405491... | lld:pubmed |
| pubmed-article:11405491 | pubmed:meshHeading | pubmed-meshheading:11405491... | lld:pubmed |
| pubmed-article:11405491 | pubmed:meshHeading | pubmed-meshheading:11405491... | lld:pubmed |
| pubmed-article:11405491 | pubmed:meshHeading | pubmed-meshheading:11405491... | lld:pubmed |
| pubmed-article:11405491 | pubmed:meshHeading | pubmed-meshheading:11405491... | lld:pubmed |
| pubmed-article:11405491 | pubmed:meshHeading | pubmed-meshheading:11405491... | lld:pubmed |
| pubmed-article:11405491 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11405491 | pubmed:articleTitle | Cytokine responses in patients undergoing coronary artery bypass surgery after ischemic preconditioning. | lld:pubmed |
| pubmed-article:11405491 | pubmed:affiliation | Division of Cardiovascular Surgery, Tampere University Hospital, Finland. | lld:pubmed |
| pubmed-article:11405491 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11405491 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11405491 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:11405491 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
